Wyburn-Mason syndrome

From WikiMD's Wellness Encyclopedia

(Redirected from CAMS2)

Alternate names[edit | edit source]

Arteriovenous aneurysm of mid-brain and retina, facial nevi and mental changes; Wyburn Mason syndrome; Bonnet-Decaume-Blanc syndrome; CAMS2; Cerebrofacial arteriovenous metameric syndrome type 2

Definition[edit | edit source]

Wyburn Mason's syndrome is a condition in which blood vessels do not form correctly in both the retina of one eye and a part of the brain. These malformed blood vessels are called arteriovenous malformations (AVM).

Summary[edit | edit source]

  • Wyburn Mason's syndrome is present from birth (congenital) and the cause is unknown.
  • The disorder is named for the investigator (Dr. R. Wyburn-Mason) who extensively described the disease entity in 1943.
  • Wyburn-Mason syndrome is sometimes grouped with the phakomatoses or neurocutaneous syndromes.

Epidemiology[edit | edit source]

  • Wyburn-Mason syndrome is an extremely rare disorder that appears to affect males and females in equal numbers.
  • The incidence or prevalence rates of Wyburn-Mason syndrome in the general population are unknown.

Cause[edit | edit source]

  • The exact cause of Wyburn-Mason syndrome is unknown.
  • It is considered a developmental abnormality characterized by arteriovenous malformations.
  • No specific genetic abnormality or hereditary tendencies have been identified.
  • The specific, underlying mechanism(s) that cause the vascular malformations in Wyburn-Mason syndrome are not known.
  • However, they are thought to result from abnormalities of blood vessel development during embryonic or fetal growth.

Signs and symptoms[edit | edit source]

  • The symptoms of this condition are quite variable and depend on the size, location, and shape of the AVMs.
  • Affected individuals may have no symptoms or may experience headaches, problems with vision, seizures, or partial paralysis (hemiparesis).

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.

80%-99% of people have these symptoms

30%-79% of people have these symptoms

  • Cerebral palsy
  • Facial asymmetry(Asymmetry of face)
  • Global developmental delay
  • Headache(Headaches)
  • Hemiparesis(Weakness of one side of body)
  • Intellectual disability(Mental deficiency)
  • Seizure
  • Visual loss(Loss of vision)

5%-29% of people have these symptoms

  • Abnormality of eye movement(Abnormal eye movement)
  • Cerebral hemorrhage(Bleeding in brain)
  • Dysarthria(Difficulty articulating speech)
  • Epistaxis(Bloody nose)
  • Gingival bleeding(Bleeding gums)
  • Hearing impairment(Deafness)
  • Iris hypopigmentation(Light eye color)
  • Irritability(Irritable)
  • Loss of consciousness(Passing out)
  • Nausea and vomiting
  • Proptosis(Bulging eye)
  • Subarachnoid hemorrhage
  • Tinnitus(Ringing in ears)

Diagnosis[edit | edit source]

  • A diagnosis of Wyburn-Mason syndrome may be made based upon a thorough clinical evaluation, a detailed patient history, and identification of characteristic findings, especially ocular findings.
  • Imaging studies such as a computed tomography (CT) scan or magnetic resonance imaging (MRI) may be performed to detect potentially dangerous central nervous system (CNS) malformations.
  • During CT scanning, a computer and x-rays are used to create a film showing cross-sectional images of certain tissue structures.
  • An MRI uses a magnetic field and radio waves to produce cross-sectional images of particular organs such as the brain.

Treatment[edit | edit source]

  • No specific treatment for Wyburn-Mason syndrome exists.
  • Treatment is directed toward the specific symptoms that are apparent in each individual.
  • Some AVMs may not require treatment, especially retinal lesions which usually remain stable.
  • If lesions in the eyes cause bleeding (hemorrhaging) in the retina or the clear, jelly-like substance that fills the middle of the eye (vitreous), laser treatment or the use of extreme cold to destroy abnormal tissue (cryosurgery) may be performed in an attempt to control the bleeding.
  • Surgical removal of the vitreous (vitrectomy) has been performed in some cases if bleeding is persistent, although surgery is controversial.


NIH genetic and rare disease info[edit source]

Wyburn-Mason syndrome is a rare disease.


Wyburn-Mason syndrome Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju